{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:43:45Z","timestamp":1774129425740,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1186\/s12978-018-0529-0","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T07:56:53Z","timestamp":1529654213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Current research on carbetocin and implications for prevention of postpartum haemorrhage"],"prefix":"10.1186","volume":"15","author":[{"given":"Fiona J.","family":"Theunissen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lester","family":"Chinery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeshita V.","family":"Pujar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"issue":"6","key":"529_CR1","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323\u201333. Available from:\n                    https:\/\/doi.org\/10.1016\/S2214-109X(14)70227-X","journal-title":"Lancet Glob Health"},{"key":"529_CR2","first-page":"4","volume-title":"WHO recommendations for the prevention and treatment of postpartum haemorrhage","author":"WHO","year":"2012","unstructured":"WHO. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: World Health Organization; 2012. p. 4. Available from: \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/75411\/1\/9789241548502_eng.pdf"},{"key":"529_CR3","unstructured":"Hogerzeil HV, GJA W, de Goeje MJ. Stability of injectable oxytocics in tropical climates: WHO report; 1993. WHO\/AP93.6. Available from: \n                    http:\/\/apps.who.int\/iris\/handle\/10665\/59411"},{"issue":"3","key":"529_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.9745\/GHSP-D-14-00043","volume":"2","author":"L Mullany","year":"2014","unstructured":"Mullany L, Newton S, Afari-Asiedu S, et al. Cumulative effects of heat exposure and storage conditions of oxytocin-in-Uniject in rural Ghana: implications for scale up. Global Health Sci Pract. 2014;2(3):285\u201394. Available from: \n                    https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25276588\n                    \n                  .","journal-title":"Global Health Sci Pract"},{"key":"529_CR5","first-page":"35","volume":"30","author":"WHO","year":"2016","unstructured":"WHO. Quality of misoprostol products. WHO Drug Inf. 2016;30:35. Available from: \n                    http:\/\/apps.who.int\/medicinedocs\/documents\/s22359en\/s22359en.pdf","journal-title":"WHO Drug Inf"},{"key":"529_CR6","doi-asserted-by":"publisher","unstructured":"Malm M, Madsen I, Kjellstr\u00f6m J. Development and stability of a heat-stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle-income countries. J Pep Sci. 2018:e3082. Available from: \n                    https:\/\/doi.org\/10.1002\/psc.3082","DOI":"10.1002\/psc.3082"},{"issue":"1","key":"529_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13063-016-1271-y","volume":"17","author":"M Widmer","year":"2016","unstructured":"Widmer M, Piaggio G, Hany A, et al. Room temperature stable carbetocin for the prevention of postpartum haemorrhage during the third stage of labour in women delivering vaginally: study protocol for a randomized controlled trial. Trials. 2016;17(1):143. Available from: \n                    https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-016-1271-y","journal-title":"Trials"},{"key":"529_CR8","unstructured":"North Bristol NHS Trust: Intramuscular Oxytocics: A Comparison Study of Intramuscular Carbetocin, Syntocinon and Syntometrine for the Third Stage of Labour Following Vaginal Birth (IMox). 2014. Available from:\n                    https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02216383"},{"key":"529_CR9","doi-asserted-by":"crossref","unstructured":"Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018; Available from: \n                    http:\/\/cochranelibrary-wiley.com\/doi\/10.1002\/14651858.CD011689.pub2\/full","DOI":"10.1002\/14651858.CD011689.pub2"},{"key":"529_CR10","volume-title":"Survey of the quality of medicines identified by the United Nations Commission on life-saving Commodities for Women and Children","author":"WHO","year":"2015","unstructured":"WHO. Survey of the quality of medicines identified by the United Nations Commission on life-saving Commodities for Women and Children. Geneva: World Health Organization; 2015. Available from: \n                    http:\/\/apps.who.int\/medicinedocs\/documents\/s23209en\/s23209en.pdf"},{"issue":"13","key":"529_CR11","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1111\/1471-0528.13998","volume":"123","author":"M Torloni","year":"2016","unstructured":"Torloni M, Gomes Freitas C, Kartoglu UH, et al. Quality of oxytocin available in low- and middle-income countries: a systematic review of the literature. BJOG Int J Obstet Gynaecol. 2016;123(13):2076\u201386. Available from: \n                    https:\/\/doi.org\/10.1111\/1471-0528.13998","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"529_CR12","doi-asserted-by":"publisher","unstructured":"Anyakora C, Oni Y, Ezedinachi U et al. Quality medicines in maternal health: results of oxytocin, misoprostol, magnesium sulfate and calcium gluconate quality audits. BMC Pregnancy Childbirth. 2018;18(1). Available from: \n                    https:\/\/doi.org\/10.1186\/s12884-018-1671-y","DOI":"10.1186\/s12884-018-1671-y"},{"key":"529_CR13","unstructured":"PATH, USAID, Reproductive Health Supplies Coalition: Buy Quality Oxytocin, Keep It Cold. 2018. Available from: \n                    https:\/\/www.rhsupplies.org\/uploads\/tx_rhscpublications\/Buy_Quality_Oxytocin__Keep_It_Cold.pdf"},{"key":"529_CR14","volume-title":"Oxytocin: adopted text for the international pharmacopoeia: final text for addition to the international pharmacopoeia (June 2010)","author":"WHO","year":"2010","unstructured":"WHO. Oxytocin: adopted text for the international pharmacopoeia: final text for addition to the international pharmacopoeia (June 2010). 4th ed. Geneva: World Health Organization; 2010. Available from: \n                    http:\/\/www.who.int\/medicines\/publications\/pharmacopoeia\/Oxytocin-mono_QAS07241FINALJune10.pdf","edition":"4"},{"key":"529_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.1992.103","volume":"52","author":"D Hunter","year":"1992","unstructured":"Hunter D, Schulz P, Wassenaar W. Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterus. Clin Pharmacol Ther. 1992;52:60\u20137. Available from: \n                    https:\/\/doi.org\/10.1038\/clpt.1992.103","journal-title":"Clin Pharmacol Ther"},{"key":"529_CR16","volume-title":"Ferring announces European approval of new room temperature stable formulation of PABAL\u00ae (Carbetocin)","author":"Ferring Pharmaceuticals","year":"2015","unstructured":"Ferring Pharmaceuticals: Ferring announces European approval of new room temperature stable formulation of PABAL\u00ae (Carbetocin). 2015. Available from: \n                    https:\/\/www.ferring.com\/en\/media\/press-releases\/pabal-new-formulation-eu-approval-7-apr-15\/"},{"key":"529_CR17","doi-asserted-by":"crossref","unstructured":"Su L, Chong Y, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012; Available from: \n                    http:\/\/cochranelibrary-wiley.com\/doi\/10.1002\/14651858.CD005457.pub4\/abstract","DOI":"10.1002\/14651858.CD005457.pub3"}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-018-0529-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12978-018-0529-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-018-0529-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T23:03:30Z","timestamp":1561158210000},"score":1,"resource":{"primary":{"URL":"https:\/\/reproductive-health-journal.biomedcentral.com\/articles\/10.1186\/s12978-018-0529-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":17,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["529"],"URL":"https:\/\/doi.org\/10.1186\/s12978-018-0529-0","relation":{},"ISSN":["1742-4755"],"issn-type":[{"value":"1742-4755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"22 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"94"}}